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Abstract: In this study, hydrophilic magnetic nanoparticles were synthesized by green routes using
a methanolic extract of Rubus ulmifolius Schott flowers. The prepared magnetic nanoparticles were
coated with carbon-based shell for drug delivery application. The nanocomposites were further
chemically functionalized with nitric acid and, sequentially, with Pluronic® F68 (CMNPs-plur) to
enhance their colloidal stability. The resulting material was dispersed in phosphate buffer solution at
pH 7.4 to study the Doxorubicin loading. After shaking for 48 h, 99.13% of the drug was loaded by the
nanocomposites. Subsequently, the drug release was studied in different working phosphate buffer
solutions (i.e., PB pH 4.5, pH 6.0 and pH 7.4) to determine the efficiency of the synthesized material
for drug delivery as pH-dependent drug nanocarrier. The results have shown a drug release quantity
18% higher in mimicking tumor environment than in the physiological one. Therefore, this study
demonstrates the ability of CMNPs-plur to release a drug with pH dependence, which could be used
in the future for the treatment of cancer "in situ" by means of controlled drug release.
Keywords: green routes; magnetic nanoparticles; drug delivery; cancer therapy; doxorubicin
1. Introduction
In the last decades, nanomaterials have been extensively studied for different applications in order
to explore their enhanced properties acquired at the nanoscale. For biomedical applications, there is a
demand to synthesize nanomaterials with optimized and combined features, such as biocompatibility,
colloidal stability, high specific surface area, and controlled shape and size, among others. To fulfill this
demand, a multidisciplinary approach is required, uniting several scientific fields, such as biomedicine,
chemical, physics, engineering, biology and pharmaceutical [1]. These nanomaterials can be developed
for combined biomedical applications, such as medical diagnosis and therapy, including target drug
delivery [2], magnetic resonance imaging (MRI) [3] and cancer hyperthermia treatment [1,4], which has
increased their interest for nanomedicine. Several methods to synthesize these nanomaterials have
been developed to find some alternatives that are applicable, efficient and with minimal side effects.
The most common used methods of synthesis are microemulsion, thermal decomposition, solvothermal,
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sonochemical, microwave-assisted, chemical vapor deposition, combustion synthesis, carbon arc,
laser pyrolysis synthesis, co-precipitation and green routes [5,6].
Green synthesis are alternative and environmental friendly ways to synthesize magnetic
nanoparticles (MNPs) [7,8], consisting on the use of plant extracts with reducing power. Typically,
green synthesis is made only by adding the plant extract in a solution containing Fe (III) and/or
Fe (II) at room temperature and stirring for a given time [9–14]. However, to obtain nanoparticles
(NPs) with the desired size, the reaction temperature must be well controlled [7,15–17]. Since this
methodology does not use many reagents and do not discard harmful components in the washing step,
this synthesis received the name of green synthesis or green routes. Also, there is the possibility of
using a concentrated basic solution added to the mixture of iron solution with vegetal extract [6,8,18].
Nevertheless, in general, bare iron oxide magnetic nanoparticles have low biocompatibility to cells
and due to their high magnetic interaction, they tend to aggregate and to form clots.
In this study, to suppress these drawbacks, MNPs synthesized by green route were coated
with carbon-based shells. Generally, these carbon-based nanocomposites have high surface area,
are chemically inert, biocompatible, thermally stable and electrically conductive [19], desirable for
biomedical applications. In addition to coating, the carbon-based magnetic nanoparticles (CMNPs)
were functionalized with nitric acid and Pluronic® F-68 (CMNPs-plur) to enhance the colloidal stability
by the incorporation of carboxylic acid and polymer groups on the carbon-based shell.
The resultant CMNPs-plur are negatively charged, enabling them to have great affinity with
cationic drugs, such as doxorubicin hydrochloride (DOX). This drug has been used successfully
to produce regression in various neoplasms, such as breast cancer, lung, bladder, thyroid and
ovary carcinoma, soft tissue sarcoma and bone sarcoma, Hodgkin’s and non-Hodgkin’s lymphomas,
neuroblastoma, Wilms’ tumor, acute lymphoblastic leukemia and acute myeloblastic leukemia [20].
The electrostatic interaction between both can be different in solutions with different pH. Such
difference can facilitate both the drug loading and the drug release depending on the solution that will
be used.
The pH-dependent drug release is very important due to the difference between the pH of
the normal tissues (pH 7.4), the extracellular environment of the tumor (pH 6.5) and the endosome
and lysosome (pH 5.0) [21]. Therefore, if more drug is released in the more acidic environment,
the treatment of the tumor will be improved and the side effects and damage to the healthy cells will
be lower. Accordingly, the main objective of this work was the development and optimization of smart
magnetic nanostructures coated with carbon materials with high potential for the cancer treatment
through the pH-dependent controlled release of drugs.
2. Materials and Methods
2.1. Chemicals and Plant Samples
The reagents used for the research were: Ammonia solution 25% (Applichem-Panreac,
Darmstadt, Germany); disodium hydrogen phosphate dodecahydrate (Na2HPO4·12H2O, Centralchem,
Bratislava Slovakia); doxorubicin hydrochloride (DOX, Discovery Fine Chemicals, Wimborne,
U.K.); ethanol absolute (Fisher Scientific, Loughborough, U.K.); formaldehyde (37–38% w/w,
Panreac, Barcelona, Spain); iron (II) chloride tetrahydrate (FeCl2·4H2O, Sigma-Aldrich, Germany);
iron (III) chloride hexahydrate pure (FeCl3·6H2O, Applichem-Panreac, Darmstadt, Germany);
Pluronic® F-68 (Sigma-Aldrich, Germany); sodium dihydrogen phosphate hydrate (NaH2PO4·H2O,
Centralchem, Bratislava, Slovakia); resorcinol (Fisher Scientific, Loughborough, U.K.); sodium
hydroxide solution (NaOH, Fisher Scientific, Loughborough, U.K.); tetraethyl orthosilicate (TEOS,
Fluka Cheika, Germany).
Rubus ulmifolius Schott flowers, Tamus communis L. shoots and Crateagus monogyna Jacq. flowers
were collected in the Natural Park of Montesinho territory, Trás-os-Montes, North-eastern Portugal, as
previously described [22–24].
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2.2. Methods
For a better understanding of the process, the following flowchart represents the steps of the used
methodology, Figure 1. Those steps will be described in detail in sequence.
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The magnetic core resulting from these three plant extracts was characterized by X-ray 
diffraction (XRD) and Transmission Electron Microscopy (TEM) in order to perform phase 
identification, determine the crystalline structure and the total core size. XRD analysis was performed 
in a PANalytical X’Pert MPD equipped with a X’Celerator detector and secondary monochromator 
(Cu Kα λ= 0.154 nm; data recorded at a 0.017° step size). The composition of magnetite present was 
identified using HighScore software and Crystallography Open Database. Rietveld refinement of the 
XRD diffraction patterns was performed using PowderCell software allowing phase quantification. 
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2.2.1. Extracts Preparation
Each plant sample (1 g) was macerated with 30 mL of methanol at 25 ◦C, 150 rpm, for 1 h.
The extract was filtered through Whatman n◦ 4 paper and the residue was then re-extracted with an
additional portion of 30 mL of methanol. The combined extracts were evaporated at 35 ◦C (rotary
evaporator Büchi R-210) to remove methanol and to obtain dry extracts.
2.2.2. Magnetic Core Synthesis and Coating
The magnetic core was synthesized according to the methodology described by Awwad & Salem
(2012) [6], i.e., using a solution of Fe(II) and Fe(III). Briefly, 0.53 g of FeCl2·4H2O and 1.11 g of
FeCl3·6H2O (1:2 molar ratio) were dissolved in 100 mL of distilled water. The vessel containing this
solution was placed in an oil bath on a magnetic stirring plate (IKA® C-MAG HS 7 with temperature
control IKA® ETS-DS)) until 30 ◦C was reached, and at this temperature, 5 mL of plant extract was
added [6]. The extract concentration was 100 times higher than the EC50 RP (EC50 Reducing Power)
concentration, i.e. the extract concentration was calculated from the method of Oyaizu (1986) to
determine reducing power [25,26]. The EC50 values correspond to the extract concentration that
provides 50% of reducing power or antioxidant activity. The lower the EC50 values means the higher
the antioxidant capacity of the samples. Different plant methanolic extracts with high reducing
power were investigated in the synthesis of magnetic cores, such as R. ulmifolius flowers (EC50 RP
40 µg·mL−1, which corresponds to the sample concentration providing 0.5 of absorbance, in the
reducing powder assay), T. communis shoots (EC50 RP 68 µg·mL−1) and C. monogyna flowers (EC50
RP 19 µg·mL−1) [22,24]. After 5 min, 30 mL of ammonium hydroxide, 1 M (from ammonia solution
25% diluted) were added dropwise to the mixture using a peristaltic pump (ISM 845, ISMATEC).
The solution remained in stirring for 1 h at 30 ◦C. A representation of this synthesis methodology can
be observed in Figure 2. The solution was washed with distilled water by centrifugation at 6000 rpm
for 5 min (MPW-260R centrifuge, MPW Med. Instruments). The washing process was repeated 7 times.
Finally, the last washing was done with ethanol and then the MNPs were dried at 60 ◦C in a drying
oven (Binder FD 115).
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Figure 2. Magnetic core synthesis methodology.
The magnetic core resulting from these three plant extracts was characterized by X-ray diffraction
(XRD) and Transmission Electron Microscopy (TEM) in order to perform phase identification,
determine the crystalline structure and the total core size. XRD analysis was performed in a PANalytical
X’Pert MPD equipped with a X’Celerator detector and secondary monochromator (Cu Kα λ = 0.154 nm;
data recorded at a 0.017◦ step size). The composition of magnetite present was identified using
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HighScore software and Crystallography Open Database. Rietveld refinement of the XRD diffraction
patterns was performed using PowderCell software allowing phase quantification. Crystallite sizes
were determined by the Williamson-Hall method [27]. TEM was performed in a Transmission
Electron Microscope LEO 906E instrument operating at 120 kV, equipped with a 4 Mpixel 28 × 28 mm
Charge-Coupled Device (CCD) camera from TRS [27]. ImageJ software (1.46r, NIH, Bethesda, MD,
USA) was used to estimate the size of the magnetic nanoparticles.
The protocol proposed by Liu et. al. (2014) was used to produce the carbon-based coating. At the
first step, 0.25 g of magnetic nanoparticles synthesized by the method previously described were
suspended in 150 mL of ethanol and 50 mL of distilled water. The mixture was ultrasonicated for
45 min (Ultrasons-H, P-Selecta) and then the solution was poured into a 500 mL round bottom flask
with 0.1 g of resorcinol and 1.4 mL of ammonia solution (25%). The mixture was remained in stirring
for 1 h at 30 ◦C in an oil bath on a magnetic stirring plate with temperature control. In the second
step, 0.15 mL of formaldehyde solution (37−40%) and 0.205 mL of tetraethyl orthosilicate (TEOS)
solution were added dropwise and the mixture was stirred for 6 h at the same temperature. After that,
the mixture was heated at 80 ◦C for 8 h under stirring. The resultant solid sample was washed 7 times
with distilled water by centrifugation at 6000 rpm for 5 min. Finally, having done the last washing with
ethanol absolute, the MNPs were dried at 60 ◦C in the drying oven. The resultant NPs were denoted
Fe3O4@polymer [19,28].
At the second step of the coating process, the Fe3O4@polymer sample was carbonized under a
N2 atmosphere in a vertical tubular furnace (ROS 50/250/12, Thermoconcept). The carbonization
occurred up to 600 ◦C at a heating rate of 1 ◦C·min−1 and the temperature was maintained at 600 ◦C
for 3 h. The resultant NPs were etched under stirring with sodium hydroxide solution (10 mol·L−1 for
24 h at room temperature) and the product was washed by centrifugation with distilled water several
times, until reaching pH 7. In the last step, the sample was washed with ethanol and dried at 60 ◦C in
a drying oven [19,28] (CMNPs).
2.2.3. Functionalization
The colloidal stability of as-synthesized CMNPs was enhanced by the chemical oxidation of
carbon-based shell at mild acid treatment followed by the incorporation of Pluronic® F-68, with the
conditions shown in Figure 3. For chemical oxidation, CMNPs were treated with nitric acid solution
(1 mol·L−1) at 60 ◦C for 3 h under stirring with temperature control. The product of the reaction was
washed by centrifugation at 6000 rpm for 5 min. The washing process was repeated several times
with distilled water, and one more time with ethanol absolute, then the sample was dried at 60 ◦C in a
drying oven.
Afterwards, 20 mg of CMNPs functionalized in nitric acid and 203.2 mg of Pluronic® F-68 was
weighed, and resuspended in 20 mL of ultrapure water. This sample was sonicated in Branson Digital
Sonifier® for 30 min in pulsed mode (15 s on and 15 s off). Then, the solution was maintained in
a shaker (Bioshake IQ, Qinstruments, Jena, Germany) for 3 h, at 25 ◦C and 6000 rpm. In sequence,
nanoparticles were washed three times with ultrapure water in ultracentrifuge (Sorvall Discovery
M120 SE, Thermo Fisher Scientific Inc., Waltham, MA, USA) at 25 ◦C and 25,000 rpm, for 30 min.
Finally, the NPs were dispersed in 5 mL of ultrapure water (CMNPs-plur).
Both the Zeta potential and DLS measurements were performed with 5 µL of the solution
CMNPs-plur (4 mg·mL−1) diluted in 1 mL of ultrapure water in Zetasizer NanoZS equipment.
The measurements were analyzed by Zetasizer software. The magnitude of the Zeta potential indicates
the degree of electrostatic repulsion between adjacent, similarly charged particles in a dispersion
and is a key indicator of colloidal suspension stability, as well. For molecules and particles that
are small enough, a high Zeta potential will confer stability, so the solution or dispersion will resist
aggregation [29].
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2.2.4. Drug Loading and Release
Phosp ate buffers (PB) with different pH were se t assess the efficiency of the developed
nanosystem as pH-dependent drug nanocarrier. The tions with pH 6.0 and 7.4 wer repared
according to Promega Protoc l & applications guide, using Na2 4·12H2O and NaH2PO4·H2O [30].
The PB at pH 4.5 was prepared using 0.05 M of the Na 2P 4·H2O solution.
The DOX loading in CMNPs functionalized with Pluronic® F-68 (CMNPs-plur) was performed as
follows: 20 mg of CMNPs-plur was firstly dissolved in 5 mL of ultrapure water and then corrected to
final volume of 20 mL with PB pH 7.4. Then, the solution was sonicated in ultrasonic bath (Ultrasonic
Compact cleaner 1 L, Powersonic PS01000A, NOTUS, Vrable, Slovakia) for 1 h. The DOX solution
was prepared by dissolving 20 mg of Doxorubicin in 5 mL of ultrapure water and then corrected to
20 mL with PB pH 7.4. This solution was placed on magnetic stirrer until a h mogeneous solution
was obtained. Next, b th CMNPs-plur and DOX solu ons were mixed together and pl ced in orbital
shaker for 48 h at room temperature with stirring (100 rpm). In sequ ce, each sample was centrifuged
2 times at 8000 rpm for 10 min. To calculate the concentration of the DOX loaded on CMNPs-plur,
the supernatants were measured at 480 nm in a UV-VIS spectrometer (Specord 40, Analytik Jena AG,
Jena, Germany). DOX loaded concentration was calculated as difference between theoretical input
DOX loading and DOX concentration in supernatant. The loading was expressed in terms of drug
loading capacity (DLC) and drug loading efficiency (DLE).
The pH-dependence release test was made in triplicate at different pH: PB pH 4.5, PB pH 6.0 and
PB pH 7.4. Around 3 mg of freeze-dried arbon-based nanoparticles fu ctionalized with Pluronic®
F-68 containing Doxorubicin (CMNPs-plur-DOX), were weighed and 1 mL of each buffer solution
were added in each flask. The flasks were placed in the orbital shaker, at 37 ◦C and after 15 min of
shaking, the mixture was centrifuged and supernatant was measured by UV-Vis spectrophotometry at
480 nm to identify the concentration of the DOX that was released in each solution. This process of
centrifugation and analysis of the supernatant was repeated in times of 15 min, 30 min, 1 h, 2 h, 3 h,
4 h, 24 h, 48 h and 72 h. From the collected data, a curve of the concentration released over time was
plotted to analyze the difference of the drug release at different pH [31].
3. Results and Discussion
3.1. Magnetic Core Synthesis and Coating
The synthesis of the magnetic cores was performed with three different plant extracts, namely
R. ulmifolius flowers, Tamus communis L. shoots and Crateagus monogyna Jacq. flowers, which were
C 2019, 5, 1 6 of 16
compared among themselves. The three types of core exhibit magnetic properties and have black color.
The yields of MNPs were very similar 516 mg, 501 mg and 416 mg, respectively. However, visibly,
the more stable magnetic core in distilled water was observed in case of R. ulmifolius flowers extract
used for magnetic core synthesis, Figure 4.
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Since the best colloidal stability of the magnetic core was obtained with the R. ulmifolius flowers
extract, this synthesis method was chosen to continue in the next experiments. In its extract, twenty-four
phenolic compounds can be identified, such as phenolic acid derivatives (di- and caffeoylquinic
acids, p-coumaroylquinic acids, feruloylquinic acids and ellagic acid), flavonoids (quercetin and
kaempferol glycoside derivatives and catechin) and hydrolysable tannins (lambertianin, sanguiin and
four di-hexahydroxydiphenol (HHDP)- galloyl glucose isomers) [25]. For the green routes synthesis,
the flavonoids are probably involved in the stages of initiation of nanoparticle formation and further
aggregation, in addition to the bioreduction stage, mainly due to the presence of various functional
groups capable of nanoparticle formation [17]. Besides the composition and reducing power of the
extract, the methodology adopted uses ammonium hydroxide to perform the synthesis of the magnetite
core by the chemical precipitation method.
TEM image presented in Figure 6a shows the bare magnetite core synthesized with R. ulmifolius
flowers extract with average size of 13.4 ± 3.5 nm. The observed agglomeration is related to the
magnetic characteristics of the sample. Figure 6b shows the TEM images of the carbon-based magnetic
nanoparticles after coating, which resulted in particles with average sizes of 20.2 ± 8.7 nm.
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3.2. Fu ct onalization
The fu ct onalization with nitric aci added various oxygen-contain ng functional groups,
such as arboxylic acid groups (−COOH) to the CMNPs structures, increasing the acidity of the
nanoc mposites. The spectral analysis measured by means of Fourier transform in rared spect ometer
(FT-IR), Figure 7, shows the comparison of the nanocomposite spectra before and aft r functionalization.
The presence of magnetite in non-functional zed CMNPs, as well as in functionalized CMNPs is
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confirmed by the absorption bands of 564 cm−1, 1628 cm−1 and 3433 cm−1. The first band corresponds
to the vibration of the Fe–O bond, and the latter two can be attributed to the bending and stretching
vibrations of the surface –OH present in the carbon-based shell [32]. The absorption bands at 1380 cm−1,
1458 cm−1, 1627 cm−1, 2923 cm−1 and 3433 cm−1 represent the C–O, O–H, C=O, C–H and O–H bonds
respectively, which indicate various oxygen-containing functional groups in the samples, including
hydroxyl (C–OH) carboxyl (COOH) and ketonic (C=O) species. Both spectra show similar behavior.
However, it is possible to observe the loss of hydroxyl groups (3433 cm−1) and Fe-O (564 cm−1) after
functionalization. The latter it could indicate oxidation in the magnetic core. Therefore, this indicates
the increase of the carboxyl groups, which are responsible for making the nanocomposites more acidic.
The presence of carboxyl groups in nanocomposites is ascribed to the enhancement of their colloidal
stability and monodispersibility in aqueous solutions [33].
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reported associated negative charge of materials fu ctionalized with Pluronic [28,34,35], resulting in a
co se e t i crease of the colloidal stability. In ad ition, the negative surface charge is attributed to the
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since it may avoid the phenomenon of ops nization (a process by which the plasma immunoproteins
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Moreover, the negative charge of the studied nanoparticles, which is advantage for the combination of
this material with the cationic drug Doxorubicin (which has NH3+ group). The DLS results showed
the average hydrodynamic diameter (DH) of CMNPs-plur sample approximately to 396 nm with
polydispersity index (PDI) of 0.27, Figure 8a. The low PDI value demonstrates the uniformity of
hydrodynamic size of the nanoparticles in the sample.
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Figure 9. Magnetic hysteresis curve of CMNPs-plur sample and magnetic core size distribution 
obtained from magnetic measurements (right inset). 
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Figure 8. Size distribution obtained by DLS (a) and Zeta potential (b) of the CMNPs-plur sample.
The superparamagnetic nanoparticles have unique domain. In a simple approximation, the total
magnetic moment of the nanoparticle can be considered as a very high magnetic moment, composed of
all the individual magnetic moments of the atoms that form the nanoparticle. The superparamagnetic
behavior is characterized by a typical relaxation time, which refers to the time required for
the systems to obtain zero magnetization after an external magnetic field is removed [34,35].
The superparamagnetis lli d to high s turation m gnetiz tion also allows the use of MNPs
for magnetic hyper hermia based in th hea gen rated by magnetic samples in the presence of an
AC m gnetic field and for cance treatment as well. The magnetic properties of the CMNPs-plur
sample were measu d by SQUID magnetometer. As it can be seen in Figur 9, superparamagnetic
behavior w s registered at 300 K. Th sample did not ex ibit hyst resis, and neither coercivity nor
remanence was detected. The saturation magnetizations of the CMNPs-plur sample was found to be
64.49 emu·g−1magnetite. Moreover, having fitted of the first quadrant of hysteresis loop by Langevin
function, the magnetic core diameter was calculated. The distribution of magnetic core diameter is
seen in Figure 9, right inset. The calculated value (DMAG = 12.1 nm) is in good agreement with the
results from XRD and TEM.
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To determine the amount of individual components (magnetite, carbon and Pluronic® F-68) in the
CMNPs-plur sample TGA was carried out. Thermogravimetric curves representing decomposition
of the different stages of the total process, namely bare magnetite, CMNPs, CMNPs-plur, as well as
Pluronic, are shown in Figure 10. Only little weight loss up to 100 ◦C, related to the humidity of all
analyzed samples (about 6%), was observed. The difference in weight losses obtained by comparing
the CMNPs with the magnetite samples was 9% and it is related to the carbon coating. The weight
loss approximately 56% corresponding to Pluronic was obtained by comparison of CMNPs-plur with
CMNPs thermograms. Considering that all Pluronic is decomposed at 800 ◦C and magnetite as
inorganic compound shows thermal stability (in the measured temperature range), then the remaining
weight of 29% corresponds to the amount of magnetite in the CMNPs-plur sample used on the drug
loading and release tests.
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Figure 10. Thermograms of the magnetite, C NPs, C NPs-plur and Pluronic.
For the study of morphology and size of prepared samples, Scanning Electron Microscopy (SEM,
JEOL7000F, JEOL Lda., Tokyo, Japan) was used. The samples for observations were prepared as
follows: 20 µL of 50-times diluted sample CMNPs-plur was placed as drop on an aluminum disc
and after evaporation of the water and sputtering with carbon the sample was observed by SEM.
The SEM image of CMNPs-plur is in Figure 11. The CMNPs-plur have an average particle diameter of
approximately 58.0 ± 17.0 nm. This considerable increase in size may be a consequence of the reaction
between the nanoparticles surface functional groups with Pluronic® F-68, by which it is possible to
form polymer aggregates around some sets of nanoparticles.
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3.3. Drug Loading and Release
Initially, the DLC (µg·µg−1) and DLE (%) were calculated using the DOX concentration in the
supernatant measured by the UV-VIS spectrometer:
DLC =
CDOX−CMNPs−plur
CCMNPs−plur
(1)
DLE(%) =
CiDOX −CfDOX
C0DOX
∗ 100 (2)
where, CDOX-CMNPs-plur is concentration of DOX loaded in the CMNPs-plur, CCMNPs-plur is
concentration of CMNPs-plur, CiDOX is initial concentration of DOX before loading, CfDOX is final
concentration of DOX in supernatant after loading. The results of drug loading are 0.991 µg·µg−1 and
99.1%, to DLC and DLE, respectively.
The pH dependent release is very important due to the difference between the pH of the normal
tissues (pH 7.4), the extracellular environment of the tumor (pH 6.5) and the endosome and lysosome
(pH 5.0) [21]. Therefore, if more drug is released in the more acidic environment, the treatment
of the tumor could be more efficient and side effects and damage of the healthy cells could be
lower. Interestingly, the drug release test revealed higher drug deliver in acidic medium. The in vitro
results show that the cumulative drug release (%) of DOX after 72 h were 19.3%, 4.4% and 1.5%,
which represent a DOX mass of 287 µg, 67 µg and 23 µg, in PB solutions with pH 4.50, pH 6.0 and pH
7.5, respectively. The drug release over time is represented in Figure 12, the standard deviation for
each pH was very small, between 0.01 and 0.25. Therefore, it is possible to evaluate that this material
has good reproducibility in the drug release tests.
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Figure 12. Drug release in percentage of DOX over time at 37 ◦C.
The results of drug release reveal that the nanocarriers have a dependent response to the pH of
the medium, releasing more DOX at mimic tumoral conditions, i.e., pH 4.5, than at physiological ones,
pH 7.4. The main reasons for this phenomenon comes from the pi–pi stacking interactions between the
carbon-based nanostructures and the aromatic DOX molecules, which can be easily disrupted under a
mild acidic environment, as well as due to the increased solubility of DOX caused by the protonation
process [28]. In this case, this pH-dependent controlled release can be also ascribed to the increased
protonation of the nanocarrier surface as the pH of the aqueous solution decreases from 7.4 to 4.5,
with the associated loss of negative surface charge. This will lead to a reduction of the electrostatic
attraction between CMNPs-plur and DOX protonated molecules, increasing the progressive drug
release [28].
4. Conclusions
The use of plant extracts in the synthesis of magnetic compounds have been explored due to their
content in phenolic compounds. The polyphenols via green routes are able to reduce the iron ions to
magnetite, which enables the formation of colloidal magnetic cores, by the incorporation of phenolic
groups, i.e., flavonoids. Improved colloidal stability enables the individual coating of the magnetic
nanomaterial to single core-shell and not clusters of magnetite with carbon. Drug loading and release
tests performed with CMNPs-plur revealed the ability to use this nanocomposite as pH-dependent
drug nanocarriers. Impressively, the synthesized nanocomposite showed an outstanding drug loading
of 99.1%. On the other hand, the final release was approximately 18% higher in solution at mimicked
acidic tumor environment than in a solution at pH equivalent to normal cells (physiological pH).
Therefore, the carbon-based magnetic nanocarriers functionalized with Pluronic® F-68 have one
possible application in the treatment of cancer by means of the pH-dependent controlled release.
Another possible clinical application to be explored is the potential of this nanomaterial for the
synergistic effect of drug delivery and hyperthermia. Due to its superparamagnetic behavior and
high magnetic saturation, this nanomaterial may have the ability to act in combination for those two
treatments in the cancer therapy.
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